Possible mechanisms underlying development of transfusion-related acute lung injury: roles of anti-major histocompatibility complex class II DR antibody.
about
Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patientsThe role of neutrophils in the pathogenesis of transfusion-related acute lung injury.Post transfusion lung injury in the neonatal population.Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.Possible involvement of heparin-binding protein in transfusion-related acute lung injury.Simultaneous five cell-lineage flow cytometric analysis system for detection of leucocyte antibodies.Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
P2860
Q33776826-5B21D8E1-0B87-4CD1-B24C-481E2406F5C7Q34118409-C95A5B8B-E28D-4BC5-981D-981DAFFC4486Q43464692-2AF7E490-4B1B-49EF-AA53-323912B3646DQ49408761-4A8F27BA-74F8-411A-87A7-B35D90667AC4Q50656014-E2AFE7A4-925B-473C-A28C-B31E6038E9D6Q50736779-EDEB01E9-281B-4C30-AA83-DFBA6928D208Q51990513-6F198AAB-0F9C-4183-A81F-1A4B30B89AB3
P2860
Possible mechanisms underlying development of transfusion-related acute lung injury: roles of anti-major histocompatibility complex class II DR antibody.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Possible mechanisms underlying ...... complex class II DR antibody.
@en
Possible mechanisms underlying ...... complex class II DR antibody.
@nl
type
label
Possible mechanisms underlying ...... complex class II DR antibody.
@en
Possible mechanisms underlying ...... complex class II DR antibody.
@nl
prefLabel
Possible mechanisms underlying ...... complex class II DR antibody.
@en
Possible mechanisms underlying ...... complex class II DR antibody.
@nl
P2093
P2860
P1433
P1476
Possible mechanisms underlying ...... complex class II DR antibody.
@en
P2093
Ishikawa Y
Mitsunaga S
Nishimura M
P2860
P304
P356
10.1046/J.1365-3148.2003.00434.X
P577
2003-06-01T00:00:00Z